Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Mar. 29, 2025	Mar. 30, 2024	Apr. 01, 2023
OPERATING ACTIVITIES
Net income	$ 171,036	$ 157,905	$ 240,841
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	19,259	18,525	16,903
Loss on infinite-lived intangible write-off	9,960	0	0
Provision for loan losses	(511)	(632)	(517)
Deferred income taxes	(6,519)	(3,081)	2,110
Stock-based compensation expense	8,683	6,760	6,264
Non-cash interest income, net	(1,028)	(1,511)	(457)
Loss (gain) on sale or retirement of property, plant and equipment, net	58	132	(281)
Gain on investments and sale of loans, net	(1,687)	(9,041)	(12,300)
Distribution of earnings from equity method investments	0	0	4,306
Changes in operating assets and liabilities, net of acquisitions
Accounts receivable	(28,771)	11,566	10,238
Proceeds from sales of consumer loans	51,078	91,514	186,017
Inventories	(11,356)	44,856	38,866
Prepaid expenses and other current assets	7,694	7,971	(20,037)
Accounts payable and accrued expenses and other current liabilities	29,444	(22,258)	(13,403)
Net cash provided by operating activities	178,496	224,682	255,693
INVESTING ACTIVITIES
Purchases of property, plant and equipment	(21,427)	(17,421)	(44,106)
Payments for acquisitions, net	0	(19,195)	(105,662)
Proceeds from sale of property, plant and equipment and assets held for sale	184	4,805	1,816
Purchases of investments	(28,115)	(13,026)	(12,533)
Proceeds from sale of investments	25,403	13,128	18,931
Return of invested capital from equity method investments	0	0	12,213
Net cash used in investing activities	(23,955)	(31,709)	(129,341)
FINANCING ACTIVITIES
Payments for taxes on stock option exercises and releases of equity awards	(3,441)	(1,988)	(1,072)
Proceeds from exercise of stock options	4,483	4,495	3,709
Payments on secured financings and other	(311)	(488)	(641)
Payments for common stock repurchases	(148,680)	(109,309)	(103,412)
Distributions to noncontrolling interest	0	(420)	(780)
Net cash used in financing activities	(147,949)	(107,710)	(102,196)
Net increase in cash, cash equivalents and restricted cash	6,592	85,263	24,156
Cash, cash equivalents and restricted cash at beginning of the fiscal year	368,753	283,490	259,334
Cash, cash equivalents and restricted cash at end of the fiscal year	375,345	368,753	283,490
Supplemental disclosures of cash flow information:
Cash paid during the year for income taxes	45,582	36,757	82,438
Cash paid during the year for interest	11	801	619
Supplemental disclosures of noncash activity:
Change in GNMA loans eligible for repurchase	(1,067)	(3,287)	(2,494)
Right-of-use assets recognized and operating lease obligations incurred	2,142	15,009	14,455
Non-cash consideration for acquisitions	0	5,430	0
Consumer loans
Changes in operating assets and liabilities, net of acquisitions
Loans receivable originated	(66,115)	(90,841)	(177,970)
Principal payments received on loans receivable	5,549	6,760	8,967
Commercial loans
Changes in operating assets and liabilities, net of acquisitions
Loans receivable originated	(143,371)	(111,245)	(132,050)
Principal payments received on loans receivable	$ 135,093	$ 117,302	$ 98,196